Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3969 results

Sort By:

Assessment of DOT Spectacles in Chinese Children Extension

Study ID: NCT07008001
Start Date: 2025-06-30
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

175

Intervention / Treatment

Novel spectacle lens design

Sponsor

SightGlass Vision, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Study of the Effectiveness of VRET Combined With tDCS in the Treatment of PTSD in Ukrainian Veterans and Civilians

Study ID: NCT06806267
Start Date: 2025-08-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

514

Intervention / Treatment

Virtual reality exposure therapy

transcranial direct current stimulation

Imaginal exposure therapy

Sponsor

Malek Bajbouj

Source: clinicaltrials.gov

Share:
Add to list

Tailoring Antibiotic Duration for Respiratory Tract Infections in Primary Care

Study ID: NCT06581367
Start Date: 2025-10-01
End Date: 2027-04-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

474

Intervention / Treatment

Tailoring the course duration to the patient's needs.

Complete a 7-day course

Sponsor

Research Foundation in Primary Attention Jordi Gol and Gurina

Source: clinicaltrials.gov

Share:
Add to list

A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)

Study ID: NCT05793567
Start Date: 2025-07
End Date: 2027-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

52

Intervention / Treatment

Coronary angiogram with coronary reactivity testing (CRT)

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Sleeping Through Menopause

Study ID: NCT06306404
Start Date: 2025-08-01
End Date: 2029-08-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

222

Intervention / Treatment

Estrogens and Progestogens

Cognitive behavioral therapy for insomnia (CBTi), and circadian rhythm therapy

Sponsor

VU University of Amsterdam

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm

Study ID: NCT06940804
Start Date: 2025-07
End Date: 2042-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

CLDN6 CAR-T

CLDN6 RNA-LPX

Sponsor

BioNTech SE

Source: clinicaltrials.gov

Share:
Add to list

A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior

Study ID: NCT06686901
Start Date: 2026-04-01
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Smartphone-delivered Therapeutic Evaluative Conditioning for Suicide (TEC-S)

Smartphone-delivered inactive Therapeutic Evaluative Conditioning

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)

Study ID: NCT06807294
Start Date: 2025-07
End Date: 2025-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

21

Intervention / Treatment

Tai chi program

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

A Multi-site, Pre-clinical, Prospective Data Collection Study in Patients Undergoing a Right Heart Catheterization

Study ID: NCT07010562
Start Date: 2025-09-01
End Date: 2026-05-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

392

Intervention / Treatment

Data collection

Sponsor

Acre now

Source: clinicaltrials.gov

Share:
Add to list

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

Study ID: NCT06260891
Start Date: 2025-11
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

34

Intervention / Treatment

25 mg/day zinc

40 mg/day zinc

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list